These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 8940474

  • 1. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
    Ruhnke M, Schmidt-Westhausen A, Engelmann E, Trautmann M.
    J Clin Microbiol; 1996 Dec; 34(12):3208-11. PubMed ID: 8940474
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.
    Espinel-Ingroff A, Rodríguez-Tudela JL, Martínez-Suárez JV.
    J Clin Microbiol; 1995 Dec; 33(12):3154-8. PubMed ID: 8586692
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [Abstract] [Full Text] [Related]

  • 4. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C, González P, Pereira A, Pérez J, Noriega LM, Palavecino E.
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
    Ruhnke M, Schmidt-Westhausen A, Trautmann M.
    Mycoses; 1996 May; 39 Suppl 2():47-50. PubMed ID: 9198745
    [Abstract] [Full Text] [Related]

  • 6. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E, Gutiérrez MJ, Aller AI, Bernal S, Martínez MA, Montero O, Quindós G.
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [Abstract] [Full Text] [Related]

  • 7. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL, Berenguer J, Martínez-Suárez JV, Sanchez R.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E, Colin S, Pichot J, Piens MA.
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [Abstract] [Full Text] [Related]

  • 9. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M.
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S, Hofmann H.
    Mycoses; 1997 Sep; 40 Suppl 1():56-63. PubMed ID: 9417515
    [Abstract] [Full Text] [Related]

  • 14. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
    Tortorano AM, Viviani MA, Barchiesi F, Arzeni D, Rigoni AL, Cogliati M, Compagnucci P, Scalise G.
    J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ.
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [Abstract] [Full Text] [Related]

  • 18. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW, Johnson EM, Rogers TR.
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [Abstract] [Full Text] [Related]

  • 19. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F, Rodríguez-Tudela JL, Martínez-Súarez JV, Polo R, Valencia E, Díaz-Guerra TM, Dronda F, Pulido F.
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK, Fothergill AW, Rinaldi MG.
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.